|
Multiple sclerosis
Citations 201-210 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Blockade of chemokine signaling in patients with multiple sclerosis
- F. Zipp, H. P. Hartung, J. Hillert, S. Schimrigk, C. Trebst, M. Stangel, C. Infante-Duarte, P. Jakobs, C. Wolf, R. Sandbrink, C. Pohl, M. Filippi for the CCR1 Antagonist Study Group
Neurology 2006; 67: 1880-1883.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Neutralizing antibodies hamper IFNß bioactivity and treatment effect on MRI in patients with MS
- P. Soelberg Sorensen, T. Tscherning, H. K. Mathiesen, A. R. Langkilde, C. Ross, M. Ravnborg, and K. Bendtzen
Neurology 2006; 67: 1681-1683.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Pathologic laughing and intractable hiccups can occur early in multiple sclerosis
- J. de Seze, H. Zephir, P. Hautecoeur, A. Mackowiak, M. Cabaret, and P. Vermersch
Neurology 2006; 67: 1684-1686.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Absence of cognitive, behavioral, or emotional dysfunction in progressive muscular atrophy
- P. Wicks, S. Abrahams, P. N. Leigh, T. Williams, and L. H. Goldstein
Neurology 2006; 67: 1718-1719.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Response of intrathecal baclofen resistance to dose reduction
- Joanna A. Cooper and Barbara Ridley
Neurology 2006; 67: 1495-1496.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Lesion pathology predicts response to plasma exchange in secondary progressive MS
- U. K. Zettl, H. P. Hartung, A. Pahnke, W. Brueck, R. Benecke, and J. Pahnke
Neurology 2006; 67: 1515-1516.
[Full text]
[PDF]
- ARTICLES
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
- L. Kappos, C. H. Polman, M. S. Freedman, G. Edan, H. P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, L. Bauer, P. Jakobs, C. Pohl, R. Sandbrink for the BENEFIT Study Group
Neurology 2006; 67: 1242-1249.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis
- John R. Rinker, II, Kathryn Trinkaus, and Anne H. Cross
Neurology 2006; 67: 1288-1290.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Liver test abnormalities in multiple sclerosis: Findings from placebo-treated patients
- H. Tremlett, S. Seemüller, Y. Zhao, E. M. Yoshida, J. Oger, and J. Petkau
Neurology 2006; 67: 1291-1293.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
- L. Kappos, A. Traboulsee, C. Constantinescu, J. -P. Erälinna, F. Forrestal, P. Jongen, J. Pollard, M. Sandberg-Wollheim, C. Sindic, B. Stubinski, B. Uitdehaag, and D. Li
Neurology 2006; 67: 944-953.
[Abstract]
[Full text]
[PDF]
|
|
